CLN8 antibody
Quick Overview for CLN8 antibody (ABIN7266285)
Target
See all CLN8 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Purpose
- CLN8 Rabbit pAb
-
Cross-Reactivity
- Human
-
Characteristics
- Polyclonal Antibodies
-
Purification
- Affinity purification
-
Immunogen
- A synthetic peptide of human CLN8.
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB,1:500 - 1:2000,IHC,1:50 - 1:300
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- CLN8 (Ceroid-Lipofuscinosis, Neuronal 8 (Epilepsy, Progressive with Mental Retardation) (CLN8))
-
Alternative Name
- CLN8
-
Background
- This gene encodes a transmembrane protein belonging to a family of proteins containing TLC domains, which are postulated to function in lipid synthesis, transport, or sensing. The protein localizes to the endoplasmic reticulum (ER), and may recycle between the ER and ER-Golgi intermediate compartment. Mutations in this gene are associated with progressive epilepsy with mental retardation (EMPR), which is a subtype of neuronal ceroid lipofuscinoses (NCL). Patients with mutations in this gene have altered levels of sphingolipid and phospholipids in the brain.,CLN8,C8orf61,EPMR,Cancer,Signal Transduction,Endocrine & Metabolism,Lipid Metabolism,Neuroscience,Neurodegenerative Diseases,CLN8
-
Gene ID
- 2055
-
UniProt
- Q9UBY8
-
Pathways
- Regulation of Cell Size, Dicarboxylic Acid Transport
Target
-